GSⅢ Implant System Acquires FDA Approval in US

– US’s FDA Approval of OSSTEM IMPLANT’s Latest Implant System, “GSⅢ Implant,” Enables Sales in the Country

OSSTEM’s “GSⅢ implant” has acquired FDA approval in the US. As the latest OSSTEM IMPLANT system released in Korea in June 2008, it has been receiving great responses from dentists.

The tapered body-type GSⅢ implant boasts of outstanding resistance to the external force experienced immediately after placement; thus enabling immediate & early loading in soft bone, appropriate final insertion torque for each bone substance, and excellent insertion depth adjustability.

Other advantages include fast insertion speed and easy path revision, allowing it to be fixed easily for drilling with small diameter. The excellent insertion depth adjustability also enhances convenience in implant operation.

OSSTEM IMPLANT disclosed that its GSⅢ implant system received great responses from clients in Korea. According to the company, the approval of US’s FDA will serve as an opportunity to fully advertise the excellence of GSⅢ in America.


Gunchi News (Korea), October 21, 2008